Ischemic Heart Disease Flashcards
Normal A-aDO2
0.3 x age or below
How do you treat ischemic heart disease?
- Sublingual Nitroglycerin
- Beta blocker
- Calcium channel blocker
- Ranolazine
stunned myocardium
Tissue that, after suffering an episode of severe acute, transient ischemia (but not necrosis), demonstrates prolonged systolic dysfunction even after the return of normal myocardial blood flow.
In general, the magnitude of stunning is proportional to the degree of the preceding ischemia, and this state is likely the pathophysiologic response to an ischemic insult that just falls short of causing irreversible necrosis.
Hibernating myocardium
Tissue that manifests chronic ventricular contractile dysfunction due to a persistently reduced blood supply, usually because of multivessel CAD. In this situation, irreversible damage has not occurred and ventricular function can promptly improve if appropriate blood flow is restored.
Stable angina
Predictable, transient chest discomfort during exertion or emotional stress. It is generally caused by fixed, obstructive atheromatous plaque in one or more coronary arteries
Stunned and hibernating myocardium contrast poorly when imaged (e.g., by echocardiography or contrast angiography) and can appear . . .
. . . indistinguishable from irreversibly infarcted heart muscle. However, they can be differentiated from necrotic regions by special imaging studies
Whether myocardium is simply stunned or hibernating vs infarcted influences the decision of whether or not to. . .
. . . undertake mechanical reperfusion procedures (percutaneous or surgical), because stunned or hibernating myocardium would be expected to improve with mechanical revascularization, whereas truly infarcted myocardium would not.
Flavors of angina
Silent ischemia
Episodes of cardiac ischemia sometimes occur in the absence of perceptible discomfort or pain. Can occur in patients who on other occasions experience typical symptomatic angina, or it may be the only manifestation of CAD.
Syndrome X
Patients with typical symptoms of angina pectoris who have no evidence of significant atherosclerotic coronary stenoses on coronary angiograms.
Some of these patients may show definite laboratory signs of ischemia during exercise testing
It is thought to be the result of pathology of resistance vessels or microvascular dysfunction, neither of which can be visualized on coronary angiography. Tends to have better prognosis than typical CAD.
Levine sign
Clenched first over sternum, as if defining the constricting discomfort by that tight grip. Indicates angina
Pathophysiologic findings of acute myocardial ischemia
Ischemia on ECG
Standard Exercise Testing
During this test, the patient exercises on a treadmill or a stationary bicycle to progressively higher workloads and is observed for the development of chest discomfort or excessive dyspnea.
The heart rate and ECG are continuously monitored, and blood pressure is checked at regular intervals. The test is continued until angina develops, signs of myocardial ischemia appear on the ECG, a target heart rate is achieved.
‘markedly positive’ (as opposed to just ‘positive’) exercise stress test
- ischemic ECG changes develop in the first 3 minutes of exercise or persist 5 minutes after exercise has stopped
- the magnitude of the ST segment depressions is >2 mm
- the systolic blood pressure abnormally falls during exercise
- high-grade ventricular arrhythmias develop
- the patient cannot exercise for at least 2 minutes because of cardiopulmonary limitations
Nuclear Imaging Studies
Radionuclide (commonly either a technetium-99m-labeled compound or thallium-201) is injected intravenously at peak exercise, after which imaging is performed. The radionuclide accumulates in proportion to the degree of perfusion of viable myocardial cells. Therefore, areas of poor perfusion appear as ‘cold spots’
Pharmacologic Stress Tests
For patients unable to exercise (e.g., those with hip or knee arthritis), pharmacologic stress testing can be performed instead using various agents, including the inotrope dobutamine (which increases myocardial oxygen demand by stimulating the heart rate and force of contraction) or the vasodilators dipyridamole or adenosine.
These pharmacologic interventions are coupled (in place of exercise) with nuclear imaging or echocardiography
Organic nitrates
- ↓ Myocardial O2 demand
- ↓ Preload (venodilatation)
- ↑ O2 supply
- ↑ Coronary perfusion
- ↓ Coronary vasospasm
β-Blockers
- ↓ Myocardial O2 demand
- ↓ Contractility
- ↓ Heart rate
Calcium channel blockers (agent specific)
- ↓ Myocardial O2 demand
- ↓ Preload (venodilatation)
- ↓ Wall stress (↓BP)
- ↓ Contractility (V, D)
- ↓ Heart rate (V, D)
- ↑ O2 supply
- ↑ Coronary perfusion
- ↓ Coronary vasospasm
Ranolazine
↓ Late phase inward sodium current
Calcium channel blockers (general description)
Antagonize voltage-gated L-type calcium channels, but the actions of the individual drugs of this group vary.
- The dihydropyridines are vasodilators
- Nondihydropyridines reduce contractility and slow HR
Short-acting vs long-acting calcium channel blockers
In meta-analyses of randomized trials, short-acting blockers have been associated with an increased incidence of MI and mortality. The adverse effect may relate to the rapid hemodynamic effects and blood pressure swings induced by the short-acting agents.
So use the long ones instead!!
Ranolazine mechanism
It is believed to inhibit the late phase of the action potential’s inward sodium current (INa+) in ventricular myocytes.
That late phase tends to be abnormally enhanced in ischemic myocardium, and the associated increased sodium influx results in higher-than-normal intracellular Ca++. This calcium overload is thought to result in impaired diastolic relaxation and contractile inefficiency.
Clopidogrel
A thienopyridine. Novel antiplatelet agents that block the platelet P2Y12 ADP receptor, thereby preventing platelet activation and aggregation.
When revascularization is pursued
- the patient’s symptoms of angina do not respond adequately to antianginal drug therapy
- unacceptable side effects of medications occur
- the patient is found to have high-risk coronary disease for which revascularization is known to improve survival
Percutaneous transluminal coronary angioplasty
A procedure performed under fluoroscopy in which a balloontipped catheter is inserted through a peripheral artery (usually, femoral, brachial, or radial) and maneuvered into the stenotic segment of a coronary vessel, then inflated to dilate the vessel and removed.
Placement of CA stent